Subject: Review Article | RC648-665 | Diseases of the endocrine glands. Clinical endocrinology | Article Subject | /
mesheuropmc: endocrine system diseases | nutritional and metabolic diseases | female genital diseases and pregnancy complications
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder amongst women of reproductive age. Although PCOS is diagnosed exclusively based on reproductive criteria, it is also a metabolic disorder. Insulin resistance, impaired glucose tolerance, type 2 diabe... View more
 A. Bargiota and E. Diamanti-Kandarakis, “The eefcts of old, new and emerging medicines on metabolic aberrations in PCOS,” eThrapeutic Advances in Endocrinology and Metabolism , vol. 3, no. 1, pp. 27-47, 2012.
 W. A. March, V. M. Moore, K. J. Willson, D. I. W. Phillips, R. J. Norman, and M. J. Davies, “eTh prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria,” Human Reproduction, vol. 25, no. 2, pp. 544-551, 2010.
 J. A. Tomlinson, J. H. Pinkney, P. Evans, A. Millward, and E. Stenhouse, “Screening for diabetes and cardiometabolic disease in women with polycystic ovary syndrome,” British Journal of Diabetes and Vascular Disease, vol. 13, no. 3, pp. 115-123, 2013.
 L. K. Hofman and D. A. Ehrmann, “Cardiometabolic features of polycystic ovary syndrome,” Nature Clinical Practice Endocrinology & Metabolism, vol. 4, no. 4, pp. 215-222, 2008.
 H. Teede, A. Deeks, and L. Moran, “Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan,” BMC Medicine, vol. 8, article 41, 2010.
 E. Diamanti-Kandarakis and A. Dunaif, “Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications,” Endocrine Reviews, vol. 33, no. 6, pp. 981-1030, 2012.
 L. J. Moran, M. L. Misso, R. A. Wild, and R. J. Norman, “Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis,” Human Reproduction Update, vol. 16, no. 4, pp. 347-363, 2010.
 H. S. Randeva, B. K. Tan, M. O. Weickert et al., “Cardiometabolic aspects of the polycystic ovary syndrome,” Endocrine Reviews, vol. 33, no. 5, pp. 812-841, 2012.
 F. Orio Jr., S. Palomba, T. Cascella et al., “Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4588-4593, 2004.
 H. F. Escobar-Morreale, M. Luque-Ram´ırez, and F. Gonza´lez, “Circulating inaflmmatory markers in polycystic ovary syndrome: a systematic review and metaanalysis,” Fertility and Sterility, vol. 95, no. 3, pp. 1048.e2-1058.e2, 2011.